☆ 4.4 Article

Comparative cost-effectiveness of nivolumab first-line and second-line therapy for advanced esophageal cancer in Japan

EUROPEAN JOURNAL OF HEALTH ECONOMICS (2023)

Related references

Note: Only part of the references are listed.

Article Medicine, General & Internal

Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma

Y. Doki et al.

Summary: In patients with advanced esophageal squamous-cell carcinoma, both first-line treatment with nivolumab plus chemotherapy and first-line treatment with nivolumab plus ipilimumab resulted in significantly longer overall survival than chemotherapy alone, with no new safety signals identified.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Pharmacology & Pharmacy

Cost-Effectiveness of First-Line Nivolumab Plus Ipilimumab Combination Therapy in Advanced Non-Small-Cell Lung Cancer in Japan

Xiuting Mo et al.

Summary: This study evaluated the cost-effectiveness of NIV + IPI combination therapy compared to chemotherapy in the treatment of advanced non-small-cell lung cancer (NSCLC) in Japanese settings. The results showed that compared to chemotherapy, NIV + IPI therapy incurred additional costs and conferred additional QALYs, resulting in an ICER above the willingness-to-pay threshold from the perspective of the Japanese healthcare system. Sensitivity analyses showed generally consistent results.

CLINICAL DRUG INVESTIGATION (2022)

Add to Collection

Article Public, Environmental & Occupational Health

History and Profile of Diagnosis Procedure Combination DPC Development of a Real Data Collection System for Acute Inpatient Care in Japan

Kenshi Hayashida et al.

Summary: DPC is a patient classification method developed in Japan to make acute inpatient care transparent and improve medical quality. It has been utilized in the Japanese medical service reimbursement system and has contributed to the development of regional medical care provision systems.

JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3)

Masanobu Takahashi et al.

Summary: The efficacy and safety of nivolumab versus chemotherapy in Japanese patients with advanced ESCC were evaluated in the ATTRACTION-3 trial. Nivolumab demonstrated favorable efficacy and safety compared to chemotherapy in the Japanese subpopulation, with longer OS and DOR, and similar ORR but lower DCR. Subgroup analysis consistently favored nivolumab over chemotherapy in terms of overall survival.

ESOPHAGUS (2021)

Add to Collection

Article Oncology

Cost-effectiveness analysis of nivolumab in the second-line treatment for advanced esophageal squamous cell carcinoma

Peng-Fei Zhang et al.

FUTURE ONCOLOGY (2020)

Add to Collection

Article Economics

Economic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan

Victoria Federico Paly et al.

JOURNAL OF MEDICAL ECONOMICS (2020)

Add to Collection

Article Economics

How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic Melanoma

Meng Li et al.

VALUE IN HEALTH (2019)

Add to Collection

Article Oncology

Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial

Ken Kato et al.

LANCET ONCOLOGY (2019)

Add to Collection

Article Oncology

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

K. Muro et al.

ANNALS OF ONCOLOGY (2019)

Add to Collection

Article Economics

Economic Analysis of First-Line Treatment with Cetuximab or Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer in England

Irina A. Tikhonova et al.

PHARMACOECONOMICS (2018)

Add to Collection

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Add to Collection

Article Oncology

Costs associated with febrile neutropenia in Japanese patients with primary breast cancer: post-hoc analysis of a randomized clinical trial

Osamu Miyake et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Article Oncology

Health state utilities in non-small cell lung cancer: An international study

Beenish Nafees et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)

Add to Collection

Article Geriatrics & Gerontology

Comparative economic evaluation of home-based and hospital-based palliative care for terminal cancer patients

Koki Kato et al.

GERIATRICS & GERONTOLOGY INTERNATIONAL (2017)

Add to Collection

Article Health Care Sciences & Services

Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves

Patricia Guyot et al.

BMC MEDICAL RESEARCH METHODOLOGY (2012)

Add to Collection

Review Oncology

Epidemiologic differences in esophageal cancer between Asian and Western populations

Han-Ze Zhang et al.

CHINESE JOURNAL OF CANCER (2012)

Add to Collection

Review Immunology

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

Arlene H. Sharpe et al.

NATURE IMMUNOLOGY (2007)

Add to Collection

Article Oncology

Health state utilities for metastatic breast cancer

A. Lloyd et al.

BRITISH JOURNAL OF CANCER (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.